Pfizer vaccine partially effective against Indian variant

An initial seven cases of the Indian variant were detected in Israel last week among people arriving from abroad and who have since undergo preliminary testing, the Health Ministry said.

Reuters
April 21, 2021 / 09:17 AM IST

Pfizer

Israel has registered eight cases of a coronavirus variant first identified in India and believes that the Pfizer/BioNTech vaccine is at least partially effective against it, an Isaeli health official said on Tuesday.

An initial seven cases of the Indian variant were detected in Israel last week among people arriving from abroad and who have since undergo preliminary testing, the Health Ministry said.

"The impression is that the Pfizer vaccine has efficacy against it, albeit a reduced efficacy," the ministry's director-general, Hezi Levy, told Kan public radio, saying the number of cases of the variant in Israel now stood at eight.

The ministry did not immediately respond to a Reuters request for more details on the research into the Indian variant.

Britain and Ireland have also said they are investigating the variant after detecting it within their borders.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Israel, whose population is 9.3 million, has fully vaccinated around 81% of citizens or residents over the age of 16. COVID-19 infections and hospitalisations are down sharply.
Reuters
TAGS: #coronavirus #Covid-19 #Current Affairs #India #indian variant #Pfizer
first published: Apr 21, 2021 09:17 am